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1. General Procedure for the Glycosidase Inhibition Assay 
Inhibitory potencies were determined by spectrophotometrically measuring the residual 
hydrolytic activities of the glycosidases against the respective o- (for β-glucosidase/β-
galactosidase from bovine liver and β-galactosidase from E. coli) or p-nitrophenyl α- or 
β-D-glycopyranoside, in the presence of the corresponding inhibitor. Each assay was 
performed in phosphate buffer at the optimal pH for each enzyme. The Km values for 
the different glycosidases used in the tests and the corresponding working pHs are listed 
herein: α-glucosidase (yeast), Km = 0.35 mM (pH 6.8); isomaltase (yeast) Km = 1.0 mM 
(pH 6.8), β-glucosidase (almonds), Km = 3.5 mM (pH 7.3); β-glucosidase/β-
galactosidase (bovine liver), Km = 2.0 mM (pH 7.3); β- galactosidase (E. coli), Km = 
0.12 mM (pH 7.3); α-galactosidase (coffee beans), Km = 2.0 mM (pH 6.8); trehalase 
(pig kidney), Km = 4.0 mM (pH 6.2); amyloglucosidase (Aspergillus niger), Km = 3.0 
mM (pH 5.5); β-mannosidase (Helix pomatia), Km = 0.6 mM (pH 5.5); α-mannosidase 
(jack bean), Km = 2.0 mM (pH 5.5); naringinase (Penicillium decumbens, β-
glucosidase/β-rhamnosidase activity). The reactions were initiated by addition of 
enzyme to a solution of the substrate in the absence or presence of various 
concentrations of inhibitor. After the mixture was incubated for 10-30 min at 37 ºC or 
55 ºC the reaction was quenched by addition of 1 M Na2CO3. The absorbance of the 
resulting mixture was determined at 405 nm or 505 nm. Each experiment was 
performed in duplicate using [I] = 2, 0.4, 0.08, 0.04 y 0.02 μM and [S] nearly Km value. 
In those cases were Ki values lower that 10 μM were obtained by this procedure (2α, 5, 
7 and 8 against yeast α-glucosidase), refined Ki values and the enzyme inhibition mode 
were determined from the slope of Lineweaver-Burk plots and double reciprocal 
analysis (Figures S1-S4). 
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2. Lineweaver-Burk and Double Reciprocal Analysis Plots 
 
Figure S1. Lineweaver-Burk Plot for Ki determination (1.3 μM) of 2α against α-
glucosidase (baker yeast) (pH 6.8). 
 
Figure S2. Lineweaver-Burk Plot for Ki determination (14.3 μM) of 5 against α-
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Figure S3. Lineweaver-Burk Plot for Ki determination (11.8 μM) of 7 against α-




Figure S4. Lineweaver-Burk Plot for Ki determination (6.4 μM) of 8 against α-

















Ι = 0 μΜ
Ι = 2,5 μΜ
Ι = 5 μΜ
Ι = 10 μΜ
Ι = 20 μΜ








3. Spectroscopic Data of 13β and 2β 
(1S)-2,3,4-Tri-O-acetyl-1-dodecylthio-5N,6O-oxomethylidenenojirimycin (13β): 
Column chromatography (1:5 ? 1:2 EtOAc:cyclohexane). Yield: 33 mg (6%). White 
solid. Rf 0.67 (1:1 EtOAc-cyclohexane). [α]D +4.9 (c 1.0 in DCM). 1H NMR (500 MHz, 
CDCl3) δ 5.19 (dd, 1 H, J4,5 = 10.5 Hz, J3,4 = 7.0 Hz, H-4), 5.13 (t, 1 H, J1,2 = J2,3 = 4.0 
Hz, H-2), 5.02 (dd, 1 H, H-3), 4.62 (d, 1 H, H-1), 4.33 (dd, 1 H, J6a,6b = 8.8 Hz, J5,6a = 
7.7 Hz, H-6a), 4.08 (t, 1 H, J5,6b = 8.8 Hz, H-6b), 3.90 (ddd, 1 H, H-5), 2.87-2.74 (m, 2 
H, SCH2), 2.08-1.98 (3 s, 9 H, MeCO), 1.65-1.10 (m, 20 H, CH2), 0.81 (t, 3 H, 3JH,H = 
7.0 Hz, CH3). 13C NMR (125.7 MHz, CDCl3) δ 169.8-168.7 (MeCO), 156.0 (CO), 73.6 
(C-3), 73.3 (C-2), 72.7 (C-4), 67.1 (C-6), 59.2 (C-1), 53.9 (C-5), 34.3 (SCH2), 31.9-22.7 
(CH2), 20.8-20.6 (MeCO), 14.1 (CH3). ESIMS: m/z 538.4 [M + Na]+. Anal. Calcd for 
C25H41NO8S: C 58.23, H 8.01, N 2.72, S 6.22. Found: C 57.86, H 7.73, N 2.63, S 6.47. 
 
(1S)-1-Dodecylthio-5N,6O-oxomethylidenenojirimycin (2β): Yield: 18 mg (91%). Rf 
0.80 (1:5 MeOH-EtOAc). [α]D -9.0 (c 1.3 in DMSO). 1H NMR (400 MHz, DMSO-d6) δ 
4.29 (dd, 1 H, J6a,6b = 8.6 Hz, J5,6a = 7.0 Hz, H-6a), 4.21 (d, 1 H, J1,2 = 8.0 Hz, H-1), 
4.05 (dd, 1 H, J5,6b = 4.6 Hz, H-6b), 3.60 (dd, 1 H, J4,5 = 10.0 Hz, H-5), 2.73-2.62 (m, 2 
H, SCH2), 1.52 (quint., 1 H, 3JH,H = 7.0 Hz, SCH2CH2), 1.40-1.20 (m, 18 H, CH2), 0.86 
(t, 3 H, 3JH,H = 7.0 Hz, CH3). 13C NMR (75.5 MHz, DMSO-d6) δ 156.0 (CO), 77.6-72.6 
(C-3, C-4), 74.7 (C-2), 65.8 (C-6), 62.5 (C-1), 57.9 (C-5), 33.3 (SCH2), 31.3-22.2 
(CH2), 14.0 (CH3). ESIMS: m/z 412.3 [M + Na]+. Anal. Calcd for C19H35NO5S: C 
58.58, H 9.06, N 3.60, S 8.23. Found: C 58.32, H 8.88, N 3.39, S 7.85. 
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Figure S20. 1H and 13C NMR spectra (500 MHz and 125.7 MHz, DMSO-d6) of 8 
 
 
 
 
 
 
 
 
 
